Literature DB >> 34480614

A rare de novo pure erythroid leukemia with JAK2 R683S mutation.

Rebecca Z Xu1, Aly Karsan1,2, Zhaodong Xu3, Brian R Berry4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34480614     DOI： 10.1007/s00277-021-04657-y

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  7 in total

Review 1.  Acute erythroleukemia: diagnosis and management.

Authors:  Fabio P S Santos; Carlos E Bueso-Ramos; Farhad Ravandi
Journal:  Expert Rev Hematol       Date:  2010-12       Impact factor: 2.929

Review 2.  Pure erythroid leukemia.

Authors:  Wei Wang; Sa A Wang; L Jeffrey Medeiros; Joseph D Khoury
Journal:  Am J Hematol       Date:  2017-02-03       Impact factor: 10.047

3.  Di Guglielmo's syndrome after polycythemia.

Authors:  A Bank; P R Larsen; H M Anderson
Journal:  N Engl J Med       Date:  1966-09-01       Impact factor: 91.245

Review 4.  Erythroid proliferations in myeloid neoplasms.

Authors:  Sa A Wang; Robert P Hasserjian
Journal:  Hum Pathol       Date:  2011-12-09       Impact factor: 3.466

5.  Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms.

Authors:  Hongmei Li; Robert P Hasserjian; Steven H Kroft; Alexandra M Harrington; Susan E Wheaton; Alex Pildain; Mark D Ewalt; Dita Gratzinger; Paul Hosking; Horatiu Olteanu
Journal:  Am J Clin Pathol       Date:  2016-04-22       Impact factor: 2.493

6.  Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution.

Authors:  F P S Santos; S Faderl; G Garcia-Manero; C Koller; M Beran; S O'Brien; S Pierce; E J Freireich; X Huang; G Borthakur; C Bueso-Ramos; M de Lima; M Keating; J Cortes; H Kantarjian; F Ravandi
Journal:  Leukemia       Date:  2009-09-10       Impact factor: 11.528

7.  The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.

Authors:  Ruiqi Wang; Xiaoning Gao; Li Yu
Journal:  BMC Cancer       Date:  2019-04-25       Impact factor: 4.430
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.